Maria L Gil-Cardeza
Overview
Explore the profile of Maria L Gil-Cardeza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
43
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rossi U, Gil-Cardeza M, Villaverde M, Finocchiaro L, Glikin G
Biomed Pharmacother
. 2015 Jun;
72:44-51.
PMID: 26054674
A local gene therapy scheme for the delivery of type I interferons could be an alternative for the treatment of melanoma. We evaluated the cytotoxic effects of interferon-β (IFNβ) gene...
2.
Finocchiaro L, Fondello C, Gil-Cardeza M, Rossi U, Villaverde M, Riveros M, et al.
Hum Gene Ther
. 2015 Mar;
26(6):367-76.
PMID: 25762364
We present here a nonviral immunogene therapy trial for canine malignant melanoma, an aggressive disease displaying significant clinical and histopathological overlapping with human melanoma. As a surgery adjuvant approach, it...
3.
Gil-Cardeza M, Ferri A, Cornejo P, Gomez E
Sci Total Environ
. 2014 Jul;
493:828-33.
PMID: 25000578
The accumulation of Cr in soil could be highly toxic to human health; therefore Cr soil distribution was studied in rhizosphere soils from Ricinus communis and Conium maculatum and bare...
4.
Gil-Cardeza M, Rossi U, Villaverde M, Glikin G, Finocchiaro L
Biomed Pharmacother
. 2013 Mar;
67(4):269-75.
PMID: 23453489
Bleomycin is a chemotherapeutic agent barely diffusible through the plasmatic membrane. We evaluated DNA/cationic lipids complexes (lipoplexes) as mediators of its uptake in four spontaneous canine melanoma derived cell lines...
5.
Finocchiaro L, Villaverde M, Gil-Cardeza M, Riveros M, Glikin G
Res Vet Sci
. 2011 Feb;
91(2):230-4.
PMID: 21300385
Eleven soft tissue- and five osteosarcoma canine patients were subjected to: (i) periodic subcutaneous injection of irradiated xenogeneic cells secreting hGM-CSF and hIL-2 mixed with allogeneic or autologous tumor homogenates;...